Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matej Seliskar

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Biochimica Et Biophysica Acta|November 14, 2006
Mammalian cytochromes P450--importance of tissue specificityMatej Seliskar, Damjana Rozman
Biochemical and Biophysical Research Communications|May 10, 2008
Expression of microsomal lanosterol 14alpha-demethylase (CYP51) in an engineered soluble monomeric formMatej Seliskar, Rok Kosir, Damjana Rozman
Molecular and Cellular Endocrinology|April 20, 2005
Pre-cholesterol precursors in gametogenesisDamjana Rozman, Matej Seliskar, Marko Cotman, et al.
Physiological Genomics|June 15, 2007
TNF-alpha interferes with lipid homeostasis and activates acute and proatherogenic processesKlementina Fon Tacer, Drago Kuzman, Matej Seliskar, et al.
Bioorganic & Medicinal Chemistry|October 30, 2007
Novel cholesterol biosynthesis inhibitors targeting human lanosterol 14alpha-demethylase (CYP51)Tina Korosec, Jure Acimovic, Matej Seliskar, et al.
Archives of Biochemistry and Biophysics|June 26, 2007
Conformational dynamics in the F/G segment of CYP51 from Mycobacterium tuberculosis monitored by FRETGalina I Lepesheva, Matej Seliskar, Charles G Knutson, et al.
Journal of Medicinal Chemistry|May 29, 2008
CYP53A15 of Cochliobolus lunatus, a target for natural antifungal compoundsBarbara Podobnik, Jure Stojan, Ljerka Lah, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|October 19, 2010
Inhibition of human sterol Δ7-reductase and other postlanosterol enzymes by LK-980, a novel inhibitor of cholesterol synthesisJure Acimovic, Tina Korosec, Matej Seliskar, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Biochimica Et Biophysica Acta|November 14, 2006
Mammalian cytochromes P450--importance of tissue specificityMatej Seliskar, Damjana Rozman
Biochemical and Biophysical Research Communications|May 10, 2008
Expression of microsomal lanosterol 14alpha-demethylase (CYP51) in an engineered soluble monomeric formMatej Seliskar, Rok Kosir, Damjana Rozman
Molecular and Cellular Endocrinology|April 20, 2005
Pre-cholesterol precursors in gametogenesisDamjana Rozman, Matej Seliskar, Marko Cotman, et al.
Physiological Genomics|June 15, 2007
TNF-alpha interferes with lipid homeostasis and activates acute and proatherogenic processesKlementina Fon Tacer, Drago Kuzman, Matej Seliskar, et al.
Bioorganic & Medicinal Chemistry|October 30, 2007
Novel cholesterol biosynthesis inhibitors targeting human lanosterol 14alpha-demethylase (CYP51)Tina Korosec, Jure Acimovic, Matej Seliskar, et al.
Archives of Biochemistry and Biophysics|June 26, 2007
Conformational dynamics in the F/G segment of CYP51 from Mycobacterium tuberculosis monitored by FRETGalina I Lepesheva, Matej Seliskar, Charles G Knutson, et al.
Journal of Medicinal Chemistry|May 29, 2008
CYP53A15 of Cochliobolus lunatus, a target for natural antifungal compoundsBarbara Podobnik, Jure Stojan, Ljerka Lah, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|October 19, 2010
Inhibition of human sterol Δ7-reductase and other postlanosterol enzymes by LK-980, a novel inhibitor of cholesterol synthesisJure Acimovic, Tina Korosec, Matej Seliskar, et al.
Pageof 1